153 related articles for article (PubMed ID: 9730247)
1. Structure-cytotoxic activity relationship for the toad poison bufadienolides.
Kamano Y; Kotake A; Hashima H; Inoue M; Morita H; Takeya K; Itokawa H; Nandachi N; Segawa T; Yukita A; Saitou K; Katsuyama M; Pettit GR
Bioorg Med Chem; 1998 Jul; 6(7):1103-15. PubMed ID: 9730247
[TBL] [Abstract][Full Text] [Related]
2. QSAR evaluation of the Ch'an Su and related bufadienolides against the colchicine-resistant primary liver carcinoma cell line PLC/PRF/5(1).
Kamano Y; Yamashita A; Nogawa T; Morita H; Takeya K; Itokawa H; Segawa T; Yukita A; Saito K; Katsuyama M; Pettit GR
J Med Chem; 2002 Dec; 45(25):5440-7. PubMed ID: 12459012
[TBL] [Abstract][Full Text] [Related]
3. Anti-tumor effects and 3D-quantitative structure-activity relationship analysis of bufadienolides from toad venom.
Liu JS; Deng LJ; Tian HY; Ruan ZX; Cao HH; Ye WC; Zhang DM; Yu ZL
Fitoterapia; 2019 Apr; 134():362-371. PubMed ID: 30872126
[TBL] [Abstract][Full Text] [Related]
4. Isolation and identification of l/d-lactate-conjugated bufadienolides from toad eggs revealing lactate racemization in amphibians.
Zhou S; Zheng Q; Huang X; Wang Y; Luo S; Jiang R; Wang L; Ye W; Tian H
Org Biomol Chem; 2017 Jul; 15(26):5609-5615. PubMed ID: 28639665
[TBL] [Abstract][Full Text] [Related]
5. Microbial transformation of three bufadienolides by Nocardia sp. and some insight for the cytotoxic structure-activity relationship (SAR).
Zhang J; Sun Y; Liu JH; Yu BY; Xu Q
Bioorg Med Chem Lett; 2007 Nov; 17(22):6062-5. PubMed ID: 17911017
[TBL] [Abstract][Full Text] [Related]
6. Anti-gastric cancer activity in three-dimensional tumor spheroids of bufadienolides.
Wang J; Zhang X; Li X; Zhang Y; Hou T; Wei L; Qu L; Shi L; Liu Y; Zou L; Liang X
Sci Rep; 2016 Apr; 6():24772. PubMed ID: 27098119
[TBL] [Abstract][Full Text] [Related]
7. A new bufadienolide with cytotoxic activity from the Chinese traditional drug Ch'an Su.
Xu R; Xie HQ; Deng LL; Zhang JX; Yang FM; Liu JH; Hao XJ; Zhang YH
Chin J Nat Med; 2014 Aug; 12(8):623-7. PubMed ID: 25156289
[TBL] [Abstract][Full Text] [Related]
8. Studies on cytotoxic constituents from the skin of the toad Bufo bufo gargarizans.
Zhao HY; Wu FK; Qiu YK; Wu Z; Jiang YT; Chen JY
J Asian Nat Prod Res; 2010 Sep; 12(9):793-800. PubMed ID: 20839128
[TBL] [Abstract][Full Text] [Related]
9. C23 steroids from the venom of Bufo bufo gargarizans.
Tian HY; Luo SL; Liu JS; Wang L; Wang Y; Zhang DM; Zhang XQ; Jiang RW; Ye WC
J Nat Prod; 2013 Oct; 76(10):1842-7. PubMed ID: 24050254
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxic constituents from the skin of the toad Bufo bufo gargarizans.
Wu FK; Qiu YK; Zhao HY; Wu Z; Li FM; Jiang YT; Chen JY
J Asian Nat Prod Res; 2011 Feb; 13(2):111-6. PubMed ID: 21279874
[TBL] [Abstract][Full Text] [Related]
11. Bufadienolides and their antitumor activity.
Gao H; Popescu R; Kopp B; Wang Z
Nat Prod Rep; 2011 May; 28(5):953-69. PubMed ID: 21416078
[No Abstract] [Full Text] [Related]
12. Isolation and structure of five new cancer cell growth inhibitory bufadienolides from the Chinese traditional drug Ch'an Su.
Nogawa T; Kamano Y; Yamashita A; Pettit GR
J Nat Prod; 2001 Sep; 64(9):1148-52. PubMed ID: 11575946
[TBL] [Abstract][Full Text] [Related]
13. Two new bufadienolides from the rhizomes of Helleborus thibetanus with inhibitory activities against prostate cancer cells.
Cheng W; Tan YF; Tian HY; Gong XW; Chen KL; Jiang RW
Nat Prod Res; 2014; 28(12):901-8. PubMed ID: 24697315
[TBL] [Abstract][Full Text] [Related]
14. Bufadienolides from amphibians: A promising source of anticancer prototypes for radical innovation, apoptosis triggering and Na
Sousa LQ; Machado KD; Oliveira SF; Araújo LD; Monção-Filho ED; Melo-Cavalcante AA; Vieira-Júnior GM; Ferreira PM
Toxicon; 2017 Mar; 127():63-76. PubMed ID: 28069354
[TBL] [Abstract][Full Text] [Related]
15. Three bufadienolides induce cell death in the human lung cancer cell line CL1-5 mainly through autophagy.
Huang HC; Chang WT; Lee MS; Chen HY; Chen YH; Lin CC; Lin MK
Bioorg Med Chem Lett; 2021 Jan; 31():127715. PubMed ID: 33246109
[TBL] [Abstract][Full Text] [Related]
16. Fibroblast Activation Protein α Activated Tripeptide Bufadienolide Antitumor Prodrug with Reduced Cardiotoxicity.
Deng LJ; Wang LH; Peng CK; Li YB; Huang MH; Chen MF; Lei XP; Qi M; Cen Y; Ye WC; Zhang DM; Chen WM
J Med Chem; 2017 Jul; 60(13):5320-5333. PubMed ID: 28595013
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxic profile of natural and some modified bufadienolides from toad Rhinella schneideri parotoid gland secretion.
Cunha-Filho GA; Resck IS; Cavalcanti BC; Pessoa CO; Moraes MO; Ferreira JR; Rodrigues FA; Dos Santos ML
Toxicon; 2010 Sep; 56(3):339-48. PubMed ID: 20381513
[TBL] [Abstract][Full Text] [Related]
18. New cytotoxic 19-norbufadienolide and bufogargarizin isolated from Chan Su.
Chen H; Meng YH; Guo DA; Liu X; Liu JH; Hu LH
Fitoterapia; 2015 Jul; 104():1-6. PubMed ID: 25987318
[TBL] [Abstract][Full Text] [Related]
19. Chemical profiling and cytotoxicity assay of bufadienolides in toad venom and toad skin.
Meng Q; Yau LF; Lu JG; Wu ZZ; Zhang BX; Wang JR; Jiang ZH
J Ethnopharmacol; 2016 Jul; 187():74-82. PubMed ID: 27063985
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity relationship analysis of bufadienolide-induced in vitro growth inhibitory effects on mouse and human cancer cells.
Moreno Y Banuls L; Urban E; Gelbcke M; Dufrasne F; Kopp B; Kiss R; Zehl M
J Nat Prod; 2013 Jun; 76(6):1078-84. PubMed ID: 23706005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
